Fresenius Kabi Issues Critical Software Update for Ivenix Infusion Pumps
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
The Mary K. Logan Research Grants will fund studies focused on enhancing the safety and effectiveness of health technology to improve patient care.
The correction follows reports that extended standby time or leaving the pump powered off with an administration set loaded may reduce flow delivery.
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
The new location aims to improve access to medical equipment for regional healthcare facilities.
Read MoreWith the clearances, ICU Medical introduces its new category of infusion devices, designed to address infusion delivery variability.
Read MoreBD is correcting software for its Alaris Systems Manager and CCE Infusion Adapter after identifying a risk that outdated infusion parameters could be uploaded, potentially leading to incorrect dosing.
Read MoreThe FDA has issued an early alert regarding Baxter’s recall of certain Spectrum infusion pumps due to missing motor mounting screws, which may have occurred during servicing.
Read MoreAccurate Biomed will support CAIRE customers with in-warranty repairs, including the FreeStyle Comfort portable oxygen concentrator and the company’s line of stationary oxygen concentrator products.
Read MoreBaxter is recalling certain Solution Sets with Duo-Vent Spikes due to an assembly issue that led to inverted slide clamps.
Read More
Fresenius Kabi recalled a specific lot of Ivenix LVP Primary Administration Sets due to a defect that could cause uncontrolled flow.